Wakefit Innovations Peer Comparison

NSE: WAKEFIT | BSE: 544642

₹135.03

₹-1.09 (-0.80%)

As on 30-Oct-2026IST

Market cap

₹4,477 Cr

Revenue (TTM)

₹1,489 Cr

P/E Ratio

23.7

P/B Ratio

3.9

Div. Yield

0 %

Edit

	Wakefit Innovations	Welspun Living	Sheela Foam	Euro Pratik Sales	Faze Three
Market cap (₹ Cr)	4,477	20,709	5,924	1,741	1,054
Revenue (₹ Cr)	1,489	10,331	4,031	374	940
Net Profit (₹ Cr)	189.18	439.80	193.86	87.91	30.44
Net Margin (%)	12.33	4.22	4.74	22.95	3.20
RoE (%)	23.67	8.80	6.34	29.87	6.93
Price to Earnings	23.67	47.75	27.62	20.20	34.63
Price-To-Book	3.91	4.30	1.80	5.28	2.57

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Wakefit Innovations	Welspun Living	Sheela Foam	Euro Pratik Sales	Faze Three
Operating Revenue	1,488.94	9,399.11	3,820.84	334.96	923.07
Total Income	1,534.37	9,467.91	3,875.11	343.17	932.76
Total Expenditure	1,305.88	8,605.90	3,427.47	222.01	829.61
EBITDA	183.06	793.21	393.37	112.95	93.46
Depreciation	104.45	394.09	178.58	6.21	30.74
EBIT	78.61	399.12	214.79	106.74	62.72
Interest	29.17	161.48	95.15	3.17	30.37
Other Income	45.43	68.80	54.27	8.21	9.69
Exceptional Items	-3.76	-18.97	7.93	-7.89	--
Profit before Tax	91.10	287.47	181.84	103.89	42.04
Provision for Tax	-98.07	74.58	42.38	26.73	8.47
Profit after Tax	189.18	212.89	139.46	77.16	33.57

Liabilities (₹ Cr)

	Wakefit Innovations	Welspun Living	Sheela Foam	Euro Pratik Sales	Faze Three
Shareholder's Funds	1,131.82	4,917.19	3,251.96	309.96	452.30
Minority Interest	--	60.76	8.29	10.69	--
Non-Current Liabilities	96.44	2,143.51	317.31	11.43	84.34
Current Liabilities	419.50	3,270.98	1,495.03	63.26	344.76
Total Liabilities	1,751.20	10,392.44	5,179.09	396.72	881.40

Assets (₹ Cr)

	Wakefit Innovations	Welspun Living	Sheela Foam	Euro Pratik Sales	Faze Three
Non-Current Assets	754.90	5,211.30	3,932.11	94.39	455.14
Current Assets	892.86	5,181.14	1,129.70	300.94	426.26
Total Assets	1,751.20	10,392.44	5,179.09	396.72	881.40
Total Debt*	0.00	1,802.37	713.77	11.57	269.96
Net Current Assets	473.36	1,910.16	-365.33	237.68	81.50
Contingent Liabilities	6.35	54.48	56.00	--	18.20

Cashflow (₹ Cr)

	Wakefit Innovations	Welspun Living	Sheela Foam	Euro Pratik Sales	Faze Three
Cash From Operating Activities	244.53	1,174.98	409.32	40.67	58.27
Cash Flow from Investing Activities	-498.67	-347.92	296.14	-38.64	-118.59
Cash from Financing Activities	335.51	-975.17	-715.72	0.40	62.81
Net Cash Inflow / Outflow	81.37	-148.11	-10.26	2.43	2.49

Ratios

Profitability Ratios

	Wakefit Innovations	Welspun Living	Sheela Foam	Euro Pratik Sales	Faze Three
ROCE (%)	14.56	6.41	6.76	38.35	11.88
ROE (%)	23.67	4.38	4.47	28.36	8.74
ROA (%)	14.02	2.06	2.66	23.13	4.15
EBIT Margin (%)	15.35	9.17	11.72	36.17	11.17
Net Margin (%)	12.33	2.25	3.60	22.49	3.60
Cash Profit Margin (%)	19.72	6.03	7.51	24.89	6.97

Growth Ratios

	Wakefit Innovations	Welspun Living	Sheela Foam	Euro Pratik Sales	Faze Three
Revenue Growth (%)	16.90	-10.87	11.10	17.85	33.79
EBIT Growth (%)	149.40	-40.58	19.08	12.37	1.38
Net Profit Growth (%)	640.44	-66.94	56.84	1.95	-17.44
EPS Growth (%)	306.76	-68.01	78.60	1.48	-17.44
Book Value Growth (%)	134.30	2.13	7.63	32.40	8.67

Valuation Ratios

	Wakefit Innovations	Welspun Living	Sheela Foam	Euro Pratik Sales	Faze Three
Price / Earnings	26.49	51.04	31.94	27.85	27.66
Price / Book Value	4.47	2.13	1.57	6.93	2.32
Dividend Yield (%)	0.00	0.09	0.21	0.10	0.00
EV/EBITDA	20.87	14.03	12.90	17.66	11.49
Market Cap (₹ Cr)	5,010.59	10,434.89	5,098.15	2,146.70	928.52

Solvency Ratios

	Wakefit Innovations	Welspun Living	Sheela Foam	Euro Pratik Sales	Faze Three
Debt to Equity	0.00	0.37	0.22	0.04	0.67
Short term debt to equity ratio	--	0.16	0.02	0.03	0.49
Current Ratio	2.13	1.58	0.76	4.76	1.24
Quick Ratio	1.66	0.92	0.49	2.82	0.69
Interest Coverage	4.12	2.78	2.91	33.79	2.38

Operating Efficiency Ratios

	Wakefit Innovations	Welspun Living	Sheela Foam	Euro Pratik Sales	Faze Three
Debtors to sales (%)	0.15	13.96	11.56	29.13	12.42
Asset Turnover	1.10	0.97	0.81	1.00	1.14
Receivable days	0.99	53.60	33.91	105.37	40.62
Inventory Days	44.27	78.93	31.98	119.13	76.36
Payable days	97.26	96.66	63.41	28.97	27.48
Cash Conversion Cycle	-52.00	35.87	2.48	195.53	89.50

Annual
Quarterly